Polycystic ovary syndrome (PCOS) is a common female endocrine disorder that has a detriment impact on female health. Herein, the study used a case-control analysis to sought to explore the association of rs13405728, rs12478601, and rs2479106 single nucleotide polymorphisms (SNPs) with in vitro fertilization and embryo transfer (IVF-ET) efficacy in treating PCOS. A total of 163 PCOS patients (52 cycles) were selected as the PCOS group and 171 patients with tubal factor infertility without PCOS (68 cycles) were selected as the control group. Polymerase chain reaction was used to amplify genome DNA and direct sequencing to detect SNPs. The LHCGR rs13405728, THADA rs12478601, and DENND1A rs2479106 genotypes were subsequently tested. 
| INTRODUCTION

Polycystic ovary syndrome (PCOS) initially described by Stein and
Leventhal in 1935 means a multi-phenotypic disorder identified by menstrual acyclicity and androgen excess with obvious biochemical aberrations.
1,2 PCOS and obesity are two frequently happening metabolic disorders associated with subfertility. 3 PCOS is the most frequent female endocrine disorder firstly identified during early reproductive years with prevalence between 6% and 10%. 4 Insulin resistance and hyperinsulinemia have been identified of being related to the pathogenesis of PCOS and about 80% women with PCOS suffer from hyperinsulinemia because of insulin resistance. 5 Anovulation, oligo-ovulation, presence of polycystic ovaries are several common clinical expressions of PCOS. 4 Subfertility of patients with PCOS would be aggravated by influence of abnormalities on oocyte quality, endometrial receptivity, ovulatory function as well as body mass index. 5 Therefore, therapies which include lifestyle modification such as weight loss, combined oral contraceptive pills, insulin-lowering medications and androgen receptor antagonists become necessary in order to improve cosmetic appearance and to induce fertility and ovulatory cycles. 2 During the past decades assisted reproductive technologies (ARTs) have been applied in many families in order to have healthy offspring; as one of ARTs in vitro fertilization and embryo transfer (IVF-ET) has been popular. 6 The most significant factors influencing outcomes of IVF-ET remain largely unknown in spite of increasing couples of infertility seeking for the help of IVF-ET. 7 Although IVF-ET artificially offers supports such as selecting high-quality embryos the implantation rate of patients with PCOS remains low which urges deeper investigation on that therapy. 8 Uterine receptivity and embryo quality have been reported as two main factors to bring a successful IVF-ET cycle. 9 It has been also claimed that female's age was a main cause resulting in poor reproductive outcome of IVF-ET. 6 The correlation between IVF-ET outcome and endometrial thickness or pattern has been assessed before. 10 With the development of DNA technology and boosting of genomic knowledge, genetic factors involving in failed implantation can also be explored, particularly some single nucleotide polymorphisms (SNPs) such as thrombophilic SNPs. 7, 11 LHCGR which is expressed in granulosa cells of ovary to influence ovulation via encoding luteinizing hormone/human chorionic gonadotropin receptor is mapped to chromosome 2p16.3. 12 The SNPs site LHCGR rs13405728 as a glycoprotein hormone receptor belongs to the G-protein coupled receptor family. 13 THADA which is located on chromosome 2p21, was identified first by Rippe et al. as a target gene in the thyroid benign tumor; at present, THADA has been reported as a novel type 2 diabetes mellitus (DM)-associated gene affecting pancreatic functions of beta-cell, and 2 SNPs rs13429458 and rs12478601 located in it were identified to be associated with PCOS. 14, 15 rs2479106 is located in DENND1A gene which encodes a protein charging a domain differentially expressed in normal and neoplastic cells (DENN) that play a role as nucleotide exchange factors for the GTPase Rab35. 16 It has been reported that rs2479106 in DENND1A, rs13405728 in LHCGR and rs13429458 in THADA all showed strong relation with PCOS. 17 Based on those previous studies, we aims at exploring the association of SNPs rs13405728, rs12478601, and rs2479106 with IVF-ET efficacy in treating PCOS.
| MATERIALS AND METHODS
| Study subjects
A case-control analysis of infertile women who had underwent con- for 17 days. At the 14 days after IVF-ET, HCG level was measured to diagnose gestation, and if HCG was positive, the gestation was determined to be biochemical so that the luteal support was continued.
| IVF-ET therapeutic regimens
Intrauterine gestational sac discovered by B-ultrasonography 35 days later determined that the gestation was a clinical one.
| SNP determination
According to genome wide association studies (GWAS), 3 PCOS predisposing gene SNP sites: rs13405728 (LHCGR gene), rs2479106
(DENND1A gene), and rs12478601 (THADA gene) were chosen. Their primers were designed by Primer 5.0 software and synthesized by Sangon Biotech Shang-hai Co., Ltd., Shanghai, China; Table 1 ). A total of 5 mL PB was extracted from patients on an empty stomach at the 2 to 3 days of natural menstrual cycle or at menostasis, added with ethylenediaminetetraacetic acid (EDTA) and preserved at −80 C refrigerator.
Genomic DNA was extracted by a PB DNA genome extraction kit (Tiangen, Beijing, China). Spectrophotometer (GENESYS 10S, Thermo
Fisher Scientific, Boston, Massachusetts) was used to measure absorbance (A) at the wavelength of 260 nm and 280 nm as well as calculating A 260 nm /A 280 nm . If the obtained value was greater than 1.8, the DNA specimen was considered to be in a greater purity and could be used for further experiments. Polymerase chain reaction was adopted to amplify genomic DNA with a volume of 30 μL reaction system: 10 × Pfu buffer 3 μL, dNTP Mix (10 mm) 0.6 μL, forward primer F (10 mM) 0.6 μL, reverse primer R (10 mM) 0.6 μL, template 0. 3 | RESULTS
| Baseline characteristics of study subjects in the PCOS and control groups
Initially, we analyzed the baseline characteristics of all the study subjects included. As shown in Table 2 , age, infertility duration, WHR, BMI, and family history of diabetes in the PCOS and control groups had no significant difference (P > 0.05). These results suggested that the PCOS and control groups could be used for comparison for study purposes.
| Patients with the CC genotype or the AG genotype of THADA rs12478601 had an increased risk of suffering from PCOS
Frequency distributions of genotypes of rs13405728, rs12478601, and rs2479106 in the PCOS and control groups were analyzed as illustrated in Table 3 . Both actual values and theoretical values accorded with Hardy-Weinberg genetic equilibrium with goodness of fit (P > 0.05). Genetic model analysis indicated that the dominant, recessive and addictive models in each SNP sites were statistically significant (P < 0.05). All 3 SNP sites were related to PCOS within which difference of the TT genotype frequency of rs13405728 in the two groups was significant, which indicated that T allele might be a predisposing gene of PCOS; the CC genotype frequency of rs12478601 was significantly higher in the PCOS group than in the control group, which meant that patients carrying the CC genotype had an increased risk of suffering from PCOS; AG genotype frequency of rs2479106 was also remarkably higher in the PCOS group than in the control group, which indicated that patient carrying AG genotype had an increased risk of suffering from PCOS.
3.3 | Frequency of the TG haplotype was higher, while frequencies of the CT and TT haplotypes were lower in PCOS
Shesis software was adopted to analyze the haplotype of SNP sites.
Haplotypes with frequency less than 3% were ignored and failed to be counted. Because DENND1A rs2479106 was in different chromosomes with rs13405728 THADA and THADA rs12478601, they were also excluded from analysis ( Abbreviations: CI, confidence interval; OR, odds ratio; PCOS, polycystic ovarian syndrome; SNP, single nucleotide polymorphism.
3.4 | rs13405728, rs12478601, and family history of DM were influencing factors for the occurrence of PCOS
We performed regression analysis, with PCOS or not as the dependent variable and rs13405728, rs12478601, rs2479106, age, infertility duration, WHR, BMI, and family history of DM as independent variables. As it is shown in Supporting Information Table S1 , PCOS was closely related with rs13405728, rs12478601, and family history of DM (P < 0.05).
| PCOS patients with the THADA rs13405728 TT genotype had worse IVF-ET efficacy
Subsequently, we explored that whether different genotypes of THADA rs12478601 could influence IVF-ET efficacy. Supporting Information Table S2 shows outcome indexes after IVF-ET in the PCOS and control groups. At the day of HCG injection, the PCOS group had greater E 2 value and number of oocytes retrieved, increased rate of abortion but decreased rate of fertilization and clinical gestation as well as incidence of OHSS when compared with the control group (P < 0.05). retrieved, rate of abortion as well as incidence of GDM (P < 0.05).
According to Supporting Information
3.6 | rs13405728, rs12478601, serum E 2 value as well as fertility rate were influencing factors for efficacy of IVF-ET
In order to investigate the influencing factors for efficacy of IVF-ET, we performed regression analysis, with whether gestation existed or not after PCOS patients received IVF-ET as the dependent variable and rs13405728, rs12478601, rs2479106, serum E 2 value, number of oocytes retrieved, fertility rate, rate of abortion, and incidence of OHSS as independent variables. As it is shown in Supporting Information Table S4 , whether gestation existed or not after PCOS patients received IVF-ET was related with rs13405728, rs12478601, serum E 2 value, and fertility rate, (P < 0.05).
| DISCUSSION
PCOS affecting 6 to 8% Asian women of childbearing age has been identified as a significant cardiovascular risk factor to disorders such as vascular endothelial dysfunction and dyslipidemia and has detriment influence on female health. 19 In this study, genotype and allele frequency distributions of PCOS patients were analyzed to explore the association of different genotypes of LHCGR rs13405728, THADA rs12478601, and DENND1A rs2479106 with the efficacy of IVF-ET in treating PCOS. The results showed that the LHCGR rs13405728, THADA rs12478601, and DENND1A rs2479106 were related to the efficacy of IVF-ET in treating PCOS.
Firstly, our results demonstrated that patients with the CC genotype or the AG genotype of THADA rs12478601 had an increased risk of suffering from PCOS and that frequency of the TG haplotype was higher, while frequencies of the CT and TT haplotypes were lower in PCOS.
Genetic factors are likely to exert effect on the metabolic features of PCOS; low-density lipoprotein cholesterol exhibited a notable elevation in CC genotype group than in the TC + TT genotype group at rs12478601 of THADA gene. 20 According to a previous study, THADA, one of the PCOS susceptibility genes, was found to carry risk alleles correlated with endocrine in addition to metabolic disturbances in PCOS patients of Han Chinese ancestry.
14 Secondly, rs13405728, rs12478601, and family history of DM were found to be influencing factors for the occurrence of PCOS. The significant association between increased risk of PCOS and rs12478601 has already been validated before. 21 As a previous genome-wide association study demonstrated, the SNP variants rs12478601 and rs13405728 in the THADA, DENND1A as well as LHCGR genes were found to be independently correlated with PCOS. 14 Moreover, Bindu et al. reported that a family history of DM is able to affect the phenotype of PCOS, which is in consistency with our study.
22
T A B L E 4 Frequency of the TG haplotype was higher, while frequencies of the CT and TT haplotypes were lower in PCOS 26 However, the specific mechanism by which rs13405728 and rs12478601 affect the IVF-ET efficacy requires a further study.
In conclusion, through analysis of several SNPs this study proved that PCOS patients with the LHCGR rs13405728 TT genotype, THADA rs12478601 CC genotype and DENND1A rs2479106 AG + GG genotype had worse IVF-ET efficacy. The results may set a theoretical base for patients undergoing IVF-ET to select a more suitable treatment according to their specific genotypes and thus have better therapeutic outcomes. However, the sample size included was limited, thus we plan to enlarge the sample size in the future study.
